National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

This is VAERS ID 631831

Government Disclaimer on use of this data



Case Details

VAERS ID: 631831 (history)  
Form: Version 1.0  
Age: 52.0  
Sex: Female  
Location: South Dakota  
Vaccinated:2016-04-07
Onset:2016-04-07
   Days after vaccination:0
Submitted: 2016-04-15
   Days after onset:8
Entered: 2016-04-18
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 146101D / 2 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
SMQs:, Extravasation events (injections, infusions and implants) (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US2016047614

Write-up: This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 52-year-old female patient who received BEXSERO (batch number 146101D, expiry date 30th April 2016). On 7th April 2016, the patient received BEXSERO .5 ml. On 7th April 2016, less than a day after receiving BEXSERO, the patient experienced injection site pain, injection site warmth and injection site erythema. On an unknown date, the outcome of the injection site pain, injection site warmth and injection site erythema were not recovered/not resolved. It was unknown if the reporter considered the injection site pain, injection site warmth and injection site erythema to be related to BEXSERO. Additional details were received as follows: The reporter called to report that a female adult patient received her second dose of BEXSERO on 7th April 2016 and experienced a painful, hot-to-the-touch two inch in diameter raised red mark below the injection site in the subcutaneous area. The patient called the clinic this morning, and had an appointment with the physician at the clinic on the day of reporting, and the painful event has not yet resolved.


New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=631831


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166